Cesar A. Perez - Concepedia

Author

Cesar A. Perez

Sylvester Comprehensive Cancer Center ORCID

Also Known As

C A Perez, C. A. Perez, C. Perez, C.A. Perez, Cesar A Perez, Cesar A. Perez, Cesar Augusto Perez, Cesar Augusto Pineda Pérez, Cesar Perez, Corporación Universitaria Republicana

195

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Sylvester Comprehensive Cancer Center University of Louisville Sarah Cannon New York University University of Miami

About

Cesar A. Perez is an author at Sylvester Comprehensive Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	1K
2	Cell Biology	7	7	457
3	Natural Sciences	5	5	374
4	Health Sciences	3	3	48
5	Public Health	2	2	154

Cesar A. Perez

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages Maureen A. Morrow, Elizabeth W. Mayer, Cesar A. Perez, Molecular Immunology ChromatinTranscriptional RegulationT Cell DevelopmentChromatin StructureCell Regulation	1999	135
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study John G. Laffey, Fabiana Madotto, Giacomo Bellani, The Lancet Respiratory Medicine Acute Lung InjuryPulmonary CareHealth EconomicsRespiratory Distress Syndrome (Pulmonary Critical Care)Acute Care	2017	125
Regulation of the Translation Initiation Factor eIF4F by Multiple Mechanisms in Human Cytomegalovirus-Infected Cells Derek Walsh, Cesar A. Perez, Joanna Notary, Journal of Virology Human Cytomegalovirus-infected CellsViral ReplicationSystems BiologyMolecular VirologyMultiple Mechanisms	2005	118
Eukaryotic Translation Initiation Factor 4F Architectural Alterations Accompany Translation Initiation Factor Redistribution in Poxvirus-Infected Cells Derek Walsh, Carolina Arias, Cesar A. Perez, Molecular and Cellular Biology Viral ReplicationMolecular VirologyPoxvirus-infected CellsNatural SciencesPathogenesis	2008	105
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study Roberto Lorusso, Maria Elena De Piero, Silvia Mariani, The Lancet Respiratory Medicine Acute CarePatient SafetyProspective Observational StudyOutcomes Research6-Month Outcomes	2022	73
Identification of a Lytic-Cycle Epstein-Barr Virus Gene Product That Can Regulate PKR Activation Jeremy Poppers, Matthew A. Mulvey, Cesar A. Perez, Journal of Virology	2002	62
Characterization of RNA Determinants Recognized by the Arginine- and Proline-Rich Region of Us11, a Herpes Simplex Virus Type 1-Encoded Double-Stranded RNA Binding Protein That Prevents PKR Activation David Khoo, Cesar A. Perez, Ian Mohr Journal of Virology Viral ReplicationSynthetic VirologyCellular Pkr KinaseMolecular BiologyViral Structural Protein	2002	62
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck Cesar A. Perez, Hunho Song, Luis E. Raez, Oral Oncology MedicinePhase Ii StudyHead And Neck CancerDermatologyCancer Treatment	2012	46
Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status Mark J. Amsbaugh, Mehran Yusuf, Elizabeth Cash, International Journal of Radiation OncologyBiologyPhysics Cervical CancerSmoking StatusMedicineOral CancerPathology	2016	45
PF-06939999, a potent and selective PRMT5 inhibitor, in patients with advanced or metastatic solid tumors: A phase 1 dose escalation study. Jordi Rodón, Cesar A. Perez, Kit Man Wong, Journal of Clinical Oncology PathologyTreatment-related AesPharmacotherapyTumor BiologyPre-clinical Pharmacology	2021	44

Page 1